GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GC81601 structure
    GC816012-Hydroxymelatonin
    CAS: 229018-17-1
    Purity: >98.00%

    2-Hydroxymelatonin is a major hydroxylated metabolite of Melatonin.

  • GC81602 structure
    GC81602Glucosamine sulfate potassium chloride
    CAS: 1296149-08-0
    Purity: >98.00%

    Glucosamine sulfate potassium chloride is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement.

  • GC81603 structure
    GC816034’-Phosphopantetheine
    CAS: 2226-71-3
    Purity: >97.50%

    4’-Phosphopantetheine is an orally active coenzyme A (CoA) precursor.

  • GC81604 structure
    GC81604ACSL5-IN-1
    Purity: >99.50%

    ACSL5-IN-1 (Compound A) is an ACSL5 inhibitor with body weight-reducing activity.

  • GC81605 structure
    GC81605PGK1-IN-1
    CAS: 3093312-81-0
    Purity: >99.50%

    PGK1-IN-1 (Compound 6e) is a potent and selective PGK1 inhibitor ( IC 50 : 33 nM).

  • GC81606 structure
    GC81606DX-8951 Hydroxy-acid sodium
    Purity: >98.50%

    DX-8951 Hydroxy-acid sodium is a prodrug of phosphoramide.

  • GC81607 structure
    GC81607Edutirsen
    CAS: 3034567-90-0
    Purity: >98.50%

    Edutirsen, an antisense oligonucleotide, is a 1-acylglycerol-3-phosphate O-acyltransferase ( PNPLA3 ) synthesis reducer.

  • GC81608 structure
    GC81608SGC-CK1γ-1
    CAS: 3125107-49-2
    Purity: >99.00%

    SGC-CK1γ-1 is a potent and selective probe for the CK1γ subfamily.

  • GC81609 structure
    GC81609YHV98-4
    CAS: 132858-26-5
    Purity: >98.00%

    YHV98-4 is a selective, blood-brain barrier-permeable Hv1 inhibitor with an IC 50 of 0.7 μM.

  • GC81610 structure
    GC81610SK-129
    CAS: 1919889-97-6
    Purity: >98.00%

    SK-129 is a blood-brain barrier-permeable inhibitor of α-synuclein ( αS ) oligomers with a K d of 221 nM.

  • GC81611 structure
    GC81611Nrf2-IN-4 hydrobromide
    Purity: >99.00%

    Nrf2-IN-4 (Compound PhcY) hydrobromide is a Nrf2 inhibitor.

  • GC81612 structure
    GC81612Y1693
    CAS: 2812381-74-9
    Purity: >99.50%

    Y1693 is an orally active RANKL inhibitor with a K d of 5.03 μM for hRANKL.

  • GC81614 structure
    GC81614Zotadirsen
    Purity: >98.00%

    Zotadirsen is the core component of the AOC drug Delpacibart zotadirsen (AOC1044), consisting of a phosphorodiamidate morpholino oligonucleotide (PMO) targeting exon 44 of the dystrophin gene and an SMCC linker.

  • GC81615 structure
    GC81615Isoeugenol- 13 C
    Purity: >98.00%

    Isoeugenol - 13 C (Iso-Eugenol- 13 C) is the 13 C-labeled Isoeugenol.

  • GC81616 structure
    GC81616Flumethrin-d 5
    Purity: >98.00%

    Flumethrin -d 5 (FCR 2769-d 5 ) is the deuterium labeled Flumethrin.

  • GC81617 structure
    GC81617Bis(4-morpholinyl)methane
    CAS: 5625-90-1
    Purity: >98.00%

    Bis(4-morpholinyl)methane (N,N'-Methylene-bis-morpholine) is a broad-spectrum, slow-release formaldehyde-based fungicide.

  • GC81618 structure
    GC81618Urolithin A- 13 C 6
    Purity: >99.50%

    Urolithin A - 13 C 6 is the 13 C-labeled Urolithin A.

  • GC81619 structure
    GC81619(S)-Bleximenib
    CAS: 2654081-27-1
    Purity: >96.00%

    (S)-Bleximenib (Compound 28) ((S)-JNJ-75276617) is an isoform of Bleximenib.

  • GC81620 structure
    GC81620Auristatin E-d 8
    Purity: >99.00%

    Auristatin E-d 8 is the deuterium labeled Auristatin E.

  • GC81621 structure
    GC81621Mertansine- 13 C,d 3
    Purity: >98.00%

    Mertansine - 13 C,d 3 (DM1- 13 C,d 3 ) is the 13 C- and deuterium labeled Mertansine.

  • GC81622 structure
    GC81622Dihydromyrcene
    CAS: 2436-90-0
    Purity: >90.00%

    Dihydromyrcene is a volatile terpenoid compound found in essential oil from Rosa indica L.

  • GC81623 structure
    GC81623Benzo[c]phenanthrene
    CAS: 195-19-7
    Purity: >98.00%

    Benzo[c]phenanthrene has carcinogenic activity.

  • GC81624 structure
    GC816244-Propylanisole
    CAS: 104-45-0
    Purity: >99.00%

    4-Propylanisole (p-Propylanisole) is a biochemical analysis reagent.

  • GC81625 structure
    GC81625Sodium naphthalene-1,5-disulfonate
    CAS: 1655-29-4
    Purity: >98.00%

    Sodium naphthalene-1,5-disulfonate(Sodium 1,5-naphthalenedisulfonate dibasic technical) is a metal-organic framework (MOF).